- Home
- BRAG vs FATE Comparison
BRAG vs FATE Comparison
Compare BRAG & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRAG
- FATE
- Stock Information
- Founded
- BRAG 2018
- FATE 2007
- Country
- BRAG Canada
- FATE United States
- Employees
- BRAG N/A
- FATE N/A
- Industry
- BRAG Office Equipment/Supplies/Services
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRAG Technology
- FATE Health Care
- Exchange
- BRAG Nasdaq
- FATE Nasdaq
- Market Cap
- BRAG 117.8M
- FATE 108.2M
- IPO Year
- BRAG N/A
- FATE 2013
- Fundamental
- Price
- BRAG $4.11
- FATE $0.79
- Analyst Decision
- BRAG Strong Buy
- FATE Hold
- Analyst Count
- BRAG 4
- FATE 9
- Target Price
- BRAG $7.50
- FATE $5.50
- AVG Volume (30 Days)
- BRAG 38.1K
- FATE 1.9M
- Earning Date
- BRAG 03-20-2025
- FATE 03-05-2025
- Dividend Yield
- BRAG N/A
- FATE N/A
- EPS Growth
- BRAG N/A
- FATE N/A
- EPS
- BRAG N/A
- FATE N/A
- Revenue
- BRAG $105,602,029.00
- FATE $13,631,000.00
- Revenue This Year
- BRAG $16.92
- FATE N/A
- Revenue Next Year
- BRAG $9.87
- FATE N/A
- P/E Ratio
- BRAG N/A
- FATE N/A
- Revenue Growth
- BRAG 9.07
- FATE N/A
- 52 Week Low
- BRAG $2.86
- FATE $0.76
- 52 Week High
- BRAG $7.00
- FATE $7.35
- Technical
- Relative Strength Index (RSI)
- BRAG 39.24
- FATE 33.50
- Support Level
- BRAG $4.22
- FATE $0.83
- Resistance Level
- BRAG $4.58
- FATE $0.96
- Average True Range (ATR)
- BRAG 0.20
- FATE 0.07
- MACD
- BRAG 0.00
- FATE 0.00
- Stochastic Oscillator
- BRAG 11.32
- FATE 11.15
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, United States, Croatia, and other regions.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.